☰ Menu

UK SABR Consortium Annual Professional Conference and Exhibition Programme 2023
Thursday 16 November
11.00amRegistration, welcome refreshments, exhibition and poster viewing
11.30amWelcome and introduction
Dr Fiona McDonald, Consultant Thoracic Clinical Oncologist, The Royal Marsden NHS Foundation Trust & Chair, UK SABR Consortium
11.35amChairs: Dr James Good, Consultant Clinical Oncologist, University Hospitals Birmingham NHS Foundation Trust & Aileen Duffton, Lead Research Radiographer, Beatson West of Scotland Cancer Centre, Glasgow
Opening address: SABR for pancreatic cancer
Dr Lauren E. Henke, Associate Professor in Radiation Oncology and Director GI Radiation Oncology, Seidman Cancer Centre and Case Western Reserve University, Cleveland, USA
12.00pmLiver SABR
Dr Jolyne O’Hare, Consultant Clinical Oncologist, Belfast Health and Social Care Trust and Dr Richard Lindsay, Consultant Interventional Radiologist, Belfast Health and Social Care Trust,
12.25pmSABR & systemic therapy in oligometastatic cancers: perfect partners or a tango too far?
Professor Gerry Hanna, Chair of Division, Cancer and Specialist Medicine, Belfast Health and Social Care Trust and Consultant Clinical Oncologist, Northern Ireland Cancer Centre & Professor Alastair Greystoke, Honorary Medical Oncologist, Northern Centre for Cancer Care
12.50pmQ&A and panel discussion with all speakers
1.05pmLunch, exhibition and poster viewing
2.05pmChairs: Dr Anoop Haridass, Consultant Clinical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust & John Lilley, Head of External Beam Radiotherapy Physics, Leeds Teaching Hospitals NHS Trust
Keynote address: what does the future hold for SABR?
Professor Matthias Guckenberger, Chairman of the Department for Radiation Oncology, University Hospital Zurich (USZ), and Professor at the University of Zurich (UZH), Switzerland
2.45pmSponsored session – Boston Scientific
Prostate SABR & SpaceOAR
Professor Amit Bahl, Consultant Clinical Oncologist, Bristol Haematology & Oncology Centre
3.15pmProffered papers from submitted abstracts
3.20pmRadiotherapy plan characteristics in the abc-07 trial of SBRT for locally advanced biliary tract cancer
Dr David Eaton, Head of Radiotherapy Physics, Guy’s and St Thomas’ NHS Foundation Trust
3.30pmThe effect of EUD on the change in EGFR for primary kidney SABR
Dr Anthony Carver, Clinical Scientist, University Hospitals Birmingham NHS Foundation Trust
3.40pmEvaluating dose coverage and conformity in Stereotactic Ablative Body Radiotherapy plans
Serena O’Keeffe, Principal Physicist, SRLON, Dublin, Ireland
3.50pmRefreshments, exhibition and poster viewing
4.20pmChairs: Dr Clive Peedell, Consultant Clinical Oncologist, South Tees Hospitals NHS Foundation Trust & Dr Thomas Rackley, Consultant Clinical Oncologist, Velindre University NHS Trust
Sponsored session – Elekta
Can SABR save patients and the planet?
Catherine Stanford-Edwards, Radiotherapy Clinical Scientist, Singleton Hospital, Swansea Bay University Health Board
4.50pmControversies in lung cancer SABR
Dr Daniel Cagney, Clinical Director of Radiation Oncology, Mater Private Dublin, Ireland, Dr Kevin Franks, Consultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust, Dr Fiona McDonald, Consultant Thoracic Clinical Oncologist, The Royal Marsden NHS Foundation Trust, Professor Matthias Guckenberger, Chairman of the Department for Radiation Oncology, University Hospital, Zurich (USZ), and Professor at the University of Zurich (UZH), Switzerland & Dr Jim Daniel, Head of Treatment Planning, South Tees Hospitals NHS Foundation Trust
5.30pmSABR Expansion Programme and trials update
Patricia Diez, Lead Clinical Scientist, RTTQA & Dr Rushil Patel, Lead SABR Physicist, RTTQA, Mount Vernon Cancer Centre
6.00pmClose of day one
UK SABR Consortium Annual Professional Conference and Exhibition Programme 2023
Friday 17 November
8.45amRegistration, welcome refreshments, exhibition and poster viewing
9.05am Welcome and introduction
Dr Chris Dean, Lead Stereotactic Radiotherapy Physicist, Barts Health NHS Trust & Vice-Chair, UK SABR Consortium
9.10amChairs: Helen Grimes, IGRT and Technical Development Lead Physicist in Radiotherapy, UCLH & Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust
Update on SABR re-irradiation
Dr Rebecca Muirhead, Consultant Clinical Oncologist & Dr Robert Rulach, Consultant Clinical Oncologist, Oxford University Hospitals NHS Foundation Trust
9.40amNavigating dose accumulation pathways in the reirradiation context
Dr Nick Hardcastle, Medical Physicist, Peter MacCallum Cancer Centre, Melbourne, Australia (virtual)
10.00amChair: Dr Aidan Cole, Consultant Oncologist and Senior Lecturer, Queen’s University Belfast
Complex cases in SABR
Expert panel: Dr Lauren E. Henke, Associate Professor in Radiation Oncology and Director GI Radiation Oncology, Seidman Cancer Centre and Case Western Reserve University, Cleveland, USA, Professor Gerry Hanna, Chair of Division, Cancer and Specialist Medicine, Belfast Health and Social Care Trust and Consultant Clinical Oncologist, Northern Ireland Cancer Centre, & Dr Chris Dean Clinical Scientist, Barts Health NHS Trust & Vice-Chair, UK SABR Consortium

Case presentations: Dr Kohgulakuhan Yogalingam, South Tees Hospitals NHS Foundation Trust, Dr Gerard Walls, Specialty Trainee in Clinical Oncology, Northern Ireland Cancer Centre & Dr Ramsay Singer, The Royal Marsden NHS Foundation Trust
10.50amAccuray sponsored session
Stereotactic radiosurgery avoids whole-brain radiotherapy: results of three prospective randomized trials
Prof. Dr. med. Rami El Shafie, Deputy Director,  Department of Radiation Oncology, Göttingen University Medical Center, Germany
11.20amRefreshments, exhibition and poster viewing
11.55amChairs: Patricia Diez, Lead Clinical Scientist, RTTQA, Mount Vernon Cancer Centre & Dr Rebecca Muirhead, Consultant Clinical Oncologist, University Hospitals Oxford NHS Foundation Trust
Update from study days and UK SABR Consortium sub-groups
Dr Anjali Zarkar, Consultant Clinical Oncologist, University Hospitals Birmingham NHS Foundation Trust & Stephen Riley, Lead Physicist, Sheffield Teaching Hospitals NHS Foundation Trust, Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust & Dr Katherine Aitken, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust
12.25pmProffered papers from submitted abstracts
12.30pmMulti-centre validation of a knowledge based radiotherapy planning model for lung SABR
Sarah McDermott, Medical Physicist, St Luke’s Radiation Oncology Network, Ireland
12.40pmStereotactic ablative body radiotherapy (SABR) for central and ultra-central lung tumours
Rachael Wooder, Advanced Lung Practitioner, The Christie NHS Foundation Trust
12.50pmClinical outcomes following Stereotactic Ablative Body Radiotherapy to central lung tumours
Julie Duong, Stereotactic Lead Radiographer, Mount Vernon Cancer Centre
1.00pmLunch, exhibition and poster viewing
2.00pmChairs: Louise Turtle, Research and Development Expert Practitioner, The Clatterbridge Cancer Centre NHS Foundation Trust & Marina Khan, Research & Development Lead Radiographer Guys & St Thomas’ NHS Foundation Trust
Radiographer led SABR services: optimisation of skill mix
Rebecca Pickles, Consultant Therapeutic Radiographer (Lung & Stereotactic Services), The Newcastle upon Tyne Hospitals NHS Foundation Trust & Rachael Wooder, Advanced Lung Practitioner, The Christie NHS Foundation Trust
2.30pmChair: Dr Aidan Cole, Consultant Oncologist and Senior Lecturer, Queen’s University Belfast
Debate: This house believes that due to new evidence SABR should be the standard of care for prostate cancers
For: Dr Alison Tree, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust, and Professor Suneil Jain, Clinical Oncology, Queen’s University Belfast and Consultant Clinical Oncologist, Northern Ireland Cancer Centre
Against: Mr Declan Cahill, Consultant Urological Surgeon, The Royal Marsden NHS Foundation Trust
3.15pmClosing remarks
Dr Fiona McDonald, Consultant Thoracic Clinical Oncologist, The Royal Marsden NHS Foundation Trust & Chair, UK SABR Consortium